, Tracking Stock Market Picks
Enter Symbol:

down 51.25 %

MAKO SURGICAL CORP (MAKO) downgraded to Sell by BioLogic Equity Research

Posted on: Thursday,  Dec 16, 2010  8:25 AM ET by BioLogic Equity Research

BioLogic Equity Research rated Sell MAKO SURGICAL CORP (NASDAQ: MAKO) on 12/16/2010, when the stock price was $14.62.
Since then, MAKO SURGICAL CORP has gained 105.13% as of 12/16/2013's recent price of $29.99.
If you would have followed this BioLogic Equity Research's recommendation on MAKO, you would have lost 51.25% of your investment in 1096 days.

MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific, early to mid-stage osteoarthritic knee disease. Its robotic arm systems, branded as its first generation Tactile Guidance System (TGS), and its second generation RIO Robotic Arm Interactive Orthopedic system (RIO), utilize tactile guided robotic arm technology and patient specific visualization to prepare the knee joint for the insertion and alignment of its resurfacing implants through a small incision in a minimally invasive, bone preserving and tissue sparing procedure. MAKO has an intellectual property portfolio of more than 250 licensed or owned patents and patent applications relating to the areas of computer assisted surgery, robotics, haptics and implants.

BioLogic Equity Research is an equity research firm. It focuses its research on healthcare sector including biotechnology, pharmaceuticals, and medical technology. The firm offers event-driven research with a focus on regulatory action dates; new product launches; clinical data releases; and long and short-selling opportunities. It researches early to mid-stage companies and basis the stock selection on high-alpha binary events. The firm employs fundamental analysis to conduct its research. It also provides consulting services. The firm caters to institutional investors. It was formerly known as BioLogic Investment Research LLC. BioLogic Equity Research LLC is based in Delray Beach, Florida.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/16/2010 8:25 AM Sell
as of 12/31/2010
1 Week down  -7.69 %
1 Month down  -11.01 %
3 Months down  -26.77 %
1 YTD up  3.81 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2010 12:25 PM Hold
6/25/2010 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy